| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, Chairman
5 companies
Thompson Tommy G is a Director at CNC, with reported holdings spanning 5 companies. Recent filings cover 18 purchases and 18 sales. Those positions are worth an estimated $7.1M at current prices.
Our model assigns Thompson Tommy G a middling insider score of 51/100, based on 13 past trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -27.6%.
Thompson Tommy G's largest disclosed position is in UTHR as Director, worth about $4.6M. The recent filings there lean toward selling, a net 24,470 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | UTHR United Therapeutics Corporation | Director | Sale+OE | 2,000 | $539.17 | $1,078,332.28 | -19.1% | +3.3% | - | |
| Mar 4, 2026 | UTHR United Therapeutics Corporation | Director | Sale+OE | 2,000 | $489.42 | $978,839.40 | -19.1% | +10.2% | - | |
| Dec 23, 2025 | TXMD Therapeuticsmd, Inc. | - | Buy | 8,400 | $1.67 | $14,030.52 | +56.8% | +40.9% | - | |
| Dec 18, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 910 | $500.59 | $455,533.17 | -9.7% | +4.6% | - | |
| Sep 10, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 4,560 | $403.36 | $1,839,321.60 | -35.0% | +20.1% | +27.1% | |
| May 28, 2025 | DOC Healthpeak Properties, Inc. | Director | Buy | 5,777 | $17.27 | $99,768.79 | +4.2% | +0.7% | +12.1% | |
| May 9, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 2,500 | $305.15 | $762,865.00 | -22.8% | -0.7% | +87.4% | |
| May 9, 2025 | DOC Healthpeak Properties, Inc. | Director | Buy | 5,700 | $17.36 | $98,973.66 | +4.3% | -2.9% | +12.4% | |
| Apr 14, 2025 | TXMD Therapeuticsmd, Inc. | - | Buy | 325 | $1.00 | $325.59 | +2.2% | +13.6% | +101.0% | |
| Mar 24, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 2,500 | $318.80 | $796,990.50 | -22.8% | -10.5% | +66.3% |